Lilly and Novast Laboratories Ltd. began the expansion of manufacturing and development facility capacities in Nantong, Jiangsu, China, as part of Lilly’s strategic partnership with Novast to create a platform of Lilly-branded generic medicines. The facility will be built employing a quality by design approach with leading engineering consultants, and will emphasize quality and safety at each step of the design process.   The $60 – $70 million expansion will add 260,000 sq.-ft. of manufacturing ...